Independent HPLC-tested COAs are available on request and are routinely updated per batch
Clinical Response Evaluation Timeline How well patients respond to vitamin B12 therapy can differ
Incomplete dissolution usually means aggregation, a solvent mismatch, or too little time
Synergy with Gut Health and Immune Balance Chronic inflammation and neuropathy are frequently driven by upstream factors such as: Gut barrier dysfunction Dysbiosis Metabolic stress Peptides like BPC-157 and KPV are often discussed alongside ARA-290 because they address: Intestinal permeability Mucosal inflammation Immune signaling at the gut level By reducing inflammatory load, these strategies may enhance the effectiveness of neuroprotective peptides
After first use, refrigerate at 28C and use within 30 days
Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection